| Jamie L Swafford, SLP | |
|
634 Sw Mulvane St Ste 404, Topeka, KS 66606-1678 | |
| (785) 295-8045 | |
| (785) 295-5415 |
| Full Name | Jamie L Swafford |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 634 Sw Mulvane St Ste 404, Topeka, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013355767 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3620 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jamie L Swafford, SLP 634 Sw Mulvane St Ste 404, Topeka, KS 66606-1678 Ph: () - | Jamie L Swafford, SLP 634 Sw Mulvane St Ste 404, Topeka, KS 66606-1678 Ph: (785) 295-8045 |
News Archive
A new study gives people in their 50s and 60s another reason to get off the couch and be physically active — especially if they have conditions or habits that endanger their hearts, like diabetes, high blood pressure or smoking.
Chief Research Officer Morris S. Whitcup, Ph.D., of ORC Guideline (an infoGROUP company) (NASDAQ: IUSA) will present findings of the company's recent research on the impact of social media on fair balance and pharmaceutical marketing at a Food and Drug Administration (FDA) public hearing later this week. The hearing will address the issue of fulfilling requirements for fair balance and risk disclosure in internet and social media promotions. The ORC Guideline study examined consumer habits in researching information about pharmaceutical products online.
The U.S. Food and Drug Administration has awarded a contract that may reach $220 million over the next five years to the Harvard Pilgrim Health Care Institute to continue to lead the Sentinel Operations Center and to develop a new Sentinel Innovation Center.
Scientists at the University of Edinburgh found that the drug - R-Roscovitine - helps to kill certain immune cells which can exacerbate symptoms associated with asthma.
An investigational vaccine appears generally well tolerated and effective against the most common strain of norovirus, reducing the main symptoms of the gastrointestinal (GI) infection, vomiting and/or diarrhea, by 52 percent, suggests research being presented at IDWeek 2013.
› Verified 7 days ago
Michele Mckinney, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1504 Sw 8th Ave, Topeka, KS 66606 Phone: 785-840-8507 | |
Colby C Hagen, MA-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Sw Randolph Ave, Topeka, KS 66611 Phone: 785-506-8672 | |
Jason Nickelson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3220 Sw Albright Dr, Topeka, KS 66614 Phone: 615-896-6400 | |
Gretchen L Pocisk, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 634 Sw Mulvane St Ste 404, Topeka, KS 66606 Phone: 785-295-8045 | |
Caroline C Abrahamson, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1504 Sw 8th Ave, Topeka, KS 66606 Phone: 785-354-6761 | |
Amanda M Wilson, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2660 Sw 3rd St, Topeka, KS 66606 Phone: 785-354-6116 |